Exact Mass: 319.0973

Exact Mass Matches: 319.0973

Found 120 metabolites which its exact mass value is equals to given mass value 319.0973, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tetrodotoxin

(1R,5R,6R,7R,9S,11R,12R,13S,14S)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1(7,11).0(1,6)]tetradecane-5,9,12,13,14-pentol

C11H17N3O8 (319.1016)


A quinazoline alkaloid that is a marine toxin isolated from fish such as puffer fish. It has been shown to exhibit potential neutotoxicity due to its ability to block voltage-gated sodium channels. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Tetrodotoxin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=4368-28-9 (retrieved 2024-09-06) (CAS RN: 4368-28-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   
   

Benzamil

3,5-diamino-N-(N-benzylcarbamimidoyl)-6-chloropyrazine-2-carboxamide

C13H14ClN7O (319.0948)


   

ci no 52015

Methylthioninium Chloride

C16H18ClN3S (319.091)


V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AB - Antidotes V - Various > V04 - Diagnostic agents > V04C - Other diagnostic agents > V04CG - Tests for gastric secretion COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Ibandronate

{1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl}phosphonic acid

C9H23NO7P2 (319.095)


Ibandronate is a nitrogen-containing bisphosphonate in the same class as alendronate and risedronate. Ibandronate inhibits osteoclast-mediated bone resorption. All of the bisphosphonates prevent the breakdown of bone by bone cells called osteoclasts. In persons who are at high risk for osteoporosis, bisphosphonates not only result in increased amounts of bone and bone strength, they also reduce the risk of hip fractures and other bone fractures. M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates

   

N-(p-Toluenesulfonyl)-L-phenylalanine

2-(4-methylbenzenesulfonamido)-3-phenylpropanoic acid

C16H17NO4S (319.0878)


   

5,9:7,10a-Dimethano-10aH-[1,3]dioxocino[6,5-d]pyrimidine-4,7,10,11,12-pentol, octahydro-12-(hydroxymethyl)-2-imino-,(4R,4aR,5R,7S,9S,10S,10aR,11S,12S)-

5,9:7,10a-Dimethano-10aH-[1,3]dioxocino[6,5-d]pyrimidine-4,7,10,11,12-pentol, octahydro-12-(hydroxymethyl)-2-imino-,(4R,4aR,5R,7S,9S,10S,10aR,11S,12S)-

C11H17N3O8 (319.1016)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D049990 - Membrane Transport Modulators

   

1-(2-Methylbenzo[d]oxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea

1-(2-Methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea hydrochloride

C17H13N5O2 (319.1069)


   

4,5,6,7,8-pentamethoxyfuroquinoline

4,5,6,7,8-pentamethoxyfuroquinoline

C16H17NO6 (319.1056)


   
   

7,8-Dihydroxyrutaecarpine

7,8-Dihydroxyrutaecarpine

C18H13N3O3 (319.0957)


   
   
   
   
   

physarorubinic acid B

physarorubinic acid B

C16H17NO6 (319.1056)


   

(7R,8S)-7,8-dihydroxyrutaecarpine

(7R,8S)-7,8-dihydroxyrutaecarpine

C18H13N3O3 (319.0957)


   

SCHEMBL13886471

SCHEMBL13886471

C11H17N3O8 (319.1016)


   

1,2-Dihydroxyrutaecarpine

1,2-Dihydroxyrutaecarpine

C18H13N3O3 (319.0957)


   

(S)-2-(3,4-dihydroxybenzoylamino)-3-(3,4-dihydroxyphenyl)propanol|nigerrimin B

(S)-2-(3,4-dihydroxybenzoylamino)-3-(3,4-dihydroxyphenyl)propanol|nigerrimin B

C16H17NO6 (319.1056)


   

(1R*,3S*)-1-(5-hydroxymethylfuran-2-yl)-3-carboxy-6-hydroxy-8-methoxy-1,2,3,4-tetrahydroisoquinoline

(1R*,3S*)-1-(5-hydroxymethylfuran-2-yl)-3-carboxy-6-hydroxy-8-methoxy-1,2,3,4-tetrahydroisoquinoline

C16H17NO6 (319.1056)


   

2-(3,4-dihydro-2-methoxy-4-oxoquinazolinyl)-1H-indole-3-carboxaldehyde|orirenierine B

2-(3,4-dihydro-2-methoxy-4-oxoquinazolinyl)-1H-indole-3-carboxaldehyde|orirenierine B

C18H13N3O3 (319.0957)


   
   
   
   
   
   
   

1,N2-6-Oxo-malondialdehyde-deoxyguanosine

1,N2-6-Oxo-malondialdehyde-deoxyguanosine

C13H13N5O5 (319.0917)


   
   
   
   
   

Ibandronate

Ibandronate sodium;Ibandronate sodium monohydrate;Ibandronic Acid;R484

C9H23NO7P2 (319.095)


M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates

   

N-BOC-2-(3-TRIFLUOROMETHYLPHENYL)-DL-GLYCINE

N-BOC-2-(3-TRIFLUOROMETHYLPHENYL)-DL-GLYCINE

C14H16F3NO4 (319.1031)


   

N-Boc-2-(4-trifluoromethylphenyl)-DL-glycine

N-Boc-2-(4-trifluoromethylphenyl)-DL-glycine

C14H16F3NO4 (319.1031)


   

(S)-(+)-Norepinephrine L-bitartrate

(S)-(+)-Norepinephrine L-bitartrate

C12H17NO9 (319.0903)


   

METHYL 2-((TERT-BUTOXYCARBONYL)AMINO)-5-(TRIFLUOROMETHYL)BENZOATE

METHYL 2-((TERT-BUTOXYCARBONYL)AMINO)-5-(TRIFLUOROMETHYL)BENZOATE

C14H16F3NO4 (319.1031)


   

boc-l-2,4,5-trifluorophe

boc-l-2,4,5-trifluorophe

C14H16F3NO4 (319.1031)


   

(r)-phenyl-(toluene-4-sulfonylamino)-acetic acid methyl ester

(r)-phenyl-(toluene-4-sulfonylamino)-acetic acid methyl ester

C16H17NO4S (319.0878)


   

methyl 3-[(2,4-dimethylphenyl)sulfonylamino]benzoate

methyl 3-[(2,4-dimethylphenyl)sulfonylamino]benzoate

C16H17NO4S (319.0878)


   

METHYL 2-(4-METHYLPHENYLSULFONAMIDO)-2-PHENYLACETATE

METHYL 2-(4-METHYLPHENYLSULFONAMIDO)-2-PHENYLACETATE

C16H17NO4S (319.0878)


   

(R)-2-(4-Methylphenylsulfonamido)-3-phenylpropanoicacid

(R)-2-(4-Methylphenylsulfonamido)-3-phenylpropanoicacid

C16H17NO4S (319.0878)


   

METHYL 4-(ETHYLCARBAMOYL)-2,3-DIFLUORO-[1,1-BIPHENYL]-3-CARBOXYLATE

METHYL 4-(ETHYLCARBAMOYL)-2,3-DIFLUORO-[1,1-BIPHENYL]-3-CARBOXYLATE

C17H15F2NO3 (319.102)


   

Norepinephrine Bitartrate

Norepinephrine Bitartrate

C12H17NO9 (319.0903)


   

1-Azulenesulfonic acid, 3,8-dimethyl-5-(1-methylethyl)-, sodium salt, hydrate (2:2:1)

1-Azulenesulfonic acid, 3,8-dimethyl-5-(1-methylethyl)-, sodium salt, hydrate (2:2:1)

C15H20NaO4S (319.098)


   

2-[2-(4-morpholin-4-ylanilino)-1,3-thiazol-4-yl]acetic acid

2-[2-(4-morpholin-4-ylanilino)-1,3-thiazol-4-yl]acetic acid

C15H17N3O3S (319.0991)


   

N-(2,3-Dihydro-2-oxo-1H-benzimidazol-5-yl)-3-hydroxy-2-naphthalenecarboxamide

N-(2,3-Dihydro-2-oxo-1H-benzimidazol-5-yl)-3-hydroxy-2-naphthalenecarboxamide

C18H13N3O3 (319.0957)


   

4-(6-METHOXY-2-NAPHTHYL)-6-(TRIFLUOROMETHYL)PYRIMIDIN-2-AMINE

4-(6-METHOXY-2-NAPHTHYL)-6-(TRIFLUOROMETHYL)PYRIMIDIN-2-AMINE

C16H12F3N3O (319.0932)


   

Ro 19-4603

Tert-butyl 5-methyl-6-oxo-5,6-dihydro-4h-imidazo[1,5-a]thieno[2,3-f][1,4]diazepine-3-carboxylate

C15H17N3O3S (319.0991)


   

boc-d-3,4,5-trifluorophenylalanine

boc-d-3,4,5-trifluorophenylalanine

C14H16F3NO4 (319.1031)


   

N-[5-Acetyl-2-(benzyloxy)phenyl]methanesulfonamide

N-[5-Acetyl-2-(benzyloxy)phenyl]methanesulfonamide

C16H17NO4S (319.0878)


   

(R)-ethyl 2-(1-(benzyloxycarbonyl)ethyl)thiazole-5-carboxylate

(R)-ethyl 2-(1-(benzyloxycarbonyl)ethyl)thiazole-5-carboxylate

C16H17NO4S (319.0878)


   

Fenamiphos metabolite

Fenamiphos metabolite

C13H22NO4PS (319.1007)


   

METHYL 2-((ISOPROPOXYCARBONYL)AMINO)-5-METHYL-4-(TRIFLUOROMETHYL)BENZOATE

METHYL 2-((ISOPROPOXYCARBONYL)AMINO)-5-METHYL-4-(TRIFLUOROMETHYL)BENZOATE

C14H16F3NO4 (319.1031)


   

[(1R)-1-(benzyloxycarbonylamino)-2-phenyl-ethyl]phosphinic acid

[(1R)-1-(benzyloxycarbonylamino)-2-phenyl-ethyl]phosphinic acid

C16H18NO4P (319.0973)


   

Noradrenaline tartrate

Noradrenaline tartrate

C12H17NO9 (319.0903)


   

N-p-Tosyl-L-phenylalanine

N-p-Tosyl-L-phenylalanine

C16H17NO4S (319.0878)


   

METHYL N-P-TOLUENESULFONYL-L-2-PHENYLGLYCINATE

METHYL N-P-TOLUENESULFONYL-L-2-PHENYLGLYCINATE

C16H17NO4S (319.0878)


   

Ethyl 4-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)-3-oxobutanoate

Ethyl 4-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)-3-oxobutanoate

C16H17NO6 (319.1056)


   

boc-d-2,4,5-trifluorophe

boc-d-2,4,5-trifluorophe

C14H16F3NO4 (319.1031)


   

Febuxostat impurity 8

Febuxostat impurity 8

C16H17NO4S (319.0878)


   

9,10 - dimethylacridinium methyl sulfate

9,10 - dimethylacridinium methyl sulfate

C16H17NO4S (319.0878)


   

3-[3-Acetyl-4-hydroxy-2-(4-methoxy-phenyl)-5-oxo-2,5-dihydro-pyrrol-1-yl]-propionic acid

3-[3-Acetyl-4-hydroxy-2-(4-methoxy-phenyl)-5-oxo-2,5-dihydro-pyrrol-1-yl]-propionic acid

C16H17NO6 (319.1056)


   

Methyl 3-(benzyloxy)-1-(2,2-dihydroxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate

Methyl 3-(benzyloxy)-1-(2,2-dihydroxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate

C16H17NO6 (319.1056)


   

(3-Fluoro-4-(((4-methoxybenzyl)oxy)carbamoyl)phenyl)boronic acid

(3-Fluoro-4-(((4-methoxybenzyl)oxy)carbamoyl)phenyl)boronic acid

C15H15BFNO5 (319.1027)


   

(Trimethyl)methylcyclopentadienylplatinum(IV)

(Trimethyl)methylcyclopentadienylplatinum(IV)

C9H16Pt (319.09)


   

Norepinephrine tartrate

Norepinephrine tartrate

C12H17NO9 (319.0903)


   

2-[benzyl-(4-methylphenyl)sulfonyl-amino]acetic acid

2-[benzyl-(4-methylphenyl)sulfonyl-amino]acetic acid

C16H17NO4S (319.0878)


   

boc-l-3,4,5-trifluorophenylalanine

boc-l-3,4,5-trifluorophenylalanine

C14H16F3NO4 (319.1031)


   
   

2-([(4-Methylphenyl)sulfonyl]amino)-3-phenylpropanoic acid

2-([(4-Methylphenyl)sulfonyl]amino)-3-phenylpropanoic acid

C16H17NO4S (319.0878)


   

Glutamyl-aspartyl-glycine

Glutamyl-aspartyl-glycine

C11H17N3O8 (319.1016)


   

(11R,13S)-3-amino-5,12,13,14-tetrahydroxy-14-(hydroxymethyl)-8,10-dioxa-2-aza-4-azoniatetracyclo[7.3.1.17,11.01,6]tetradec-3-en-9-olate

(11R,13S)-3-amino-5,12,13,14-tetrahydroxy-14-(hydroxymethyl)-8,10-dioxa-2-aza-4-azoniatetracyclo[7.3.1.17,11.01,6]tetradec-3-en-9-olate

C11H17N3O8 (319.1016)


   

ibandronic acid

ibandronic acid

C9H23NO7P2 (319.095)


M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates

   

(11S,13S)-3-Amino-5,12,13,14-tetrahydroxy-14-(hydroxymethyl)-8,10-dioxa-2-aza-4-azoniatetracyclo[7.3.1.17,11.01,6]tetradec-3-en-9-olate

(11S,13S)-3-Amino-5,12,13,14-tetrahydroxy-14-(hydroxymethyl)-8,10-dioxa-2-aza-4-azoniatetracyclo[7.3.1.17,11.01,6]tetradec-3-en-9-olate

C11H17N3O8 (319.1016)


   

1-(4-Ethyl-2-pyridinyl)-3-(4-methylphenyl)sulfonylurea

1-(4-Ethyl-2-pyridinyl)-3-(4-methylphenyl)sulfonylurea

C15H17N3O3S (319.0991)


   
   
   
   

4-acetyl-3,5-dimethyl-1H-pyrrole-2-carboxylic acid (5-methoxycarbonyl-2-furanyl)methyl ester

4-acetyl-3,5-dimethyl-1H-pyrrole-2-carboxylic acid (5-methoxycarbonyl-2-furanyl)methyl ester

C16H17NO6 (319.1056)


   

N-(1,3-benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidinamine

N-(1,3-benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidinamine

C18H13N3O3 (319.0957)


   

2-(4-Chlorophenyl)-4-(ethylthio)-6-(1-pyrrolidinyl)pyrimidine

2-(4-Chlorophenyl)-4-(ethylthio)-6-(1-pyrrolidinyl)pyrimidine

C16H18ClN3S (319.091)


   
   
   
   
   
   

Aspartyl-glycyl-glutamic acid

Aspartyl-glycyl-glutamic acid

C11H17N3O8 (319.1016)


   

(11S,13S)-3-amino-14-(hydroxymethyl)-8,10-dioxa-2,4-diazatetracyclo[7.3.1.17,11.01,6]tetradec-3-ene-5,9,12,13,14-pentol

(11S,13S)-3-amino-14-(hydroxymethyl)-8,10-dioxa-2,4-diazatetracyclo[7.3.1.17,11.01,6]tetradec-3-ene-5,9,12,13,14-pentol

C11H17N3O8 (319.1016)


   

(2S)-N-(4-chloro-2-methylphenyl)-2-(4-methoxyphenoxy)propanamide

(2S)-N-(4-chloro-2-methylphenyl)-2-(4-methoxyphenoxy)propanamide

C17H18ClNO3 (319.0975)


   
   

SB 334867

1-(2-Methylbenzo[d]oxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea

C17H13N5O2 (319.1069)


   
   

Ro 67-7476

Ro 67-7476

C17H18FNO2S (319.1042)


Ro 67-7476 is a potent positive allosteric modulator of mGluR1 and potentiates glutamate-induced calcium release in HEK293 cells expressing rat mGluR1a with an EC50 of 60.1 nM[1][2]. Ro 67-7476 is a potent P-ERK1/2 agonist?and activates ERK1/2 phosphorylation in the absence of exogenously added glutamate (EC50=163.3 nM)[3].

   

18,19-dihydroxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

18,19-dihydroxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

C18H13N3O3 (319.0957)


   

4,5,6,7,8-pentamethoxyfuro[2,3-b]quinoline

4,5,6,7,8-pentamethoxyfuro[2,3-b]quinoline

C16H17NO6 (319.1056)


   

(1r,5r,6r,7r,9s,11s,12s,13s,14r)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

(1r,5r,6r,7r,9s,11s,12s,13s,14r)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

C11H17N3O8 (319.1016)


   

n-[1-(3,4-dihydroxyphenyl)-3-hydroxypropan-2-yl]-3,4-dihydroxybenzenecarboximidic acid

n-[1-(3,4-dihydroxyphenyl)-3-hydroxypropan-2-yl]-3,4-dihydroxybenzenecarboximidic acid

C16H17NO6 (319.1056)


   

(1r,5r,6s,7r,9s,11r,12r,13s,14r)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

(1r,5r,6s,7r,9s,11r,12r,13s,14r)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

C11H17N3O8 (319.1016)


   

4-benzyl-3-hydroxy-4h-pyrazino[2,1-b]quinazoline-1,6-dione

4-benzyl-3-hydroxy-4h-pyrazino[2,1-b]quinazoline-1,6-dione

C18H13N3O3 (319.0957)


   

(1r,5r,6r,7r,9s,11s,13s,14s)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

(1r,5r,6r,7r,9s,11s,13s,14s)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

C11H17N3O8 (319.1016)


   

(1r,5s,6r,7r,9s,11s,12r,13s,14s)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

(1r,5s,6r,7r,9s,11s,12r,13s,14s)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

C11H17N3O8 (319.1016)


   

methyl 2-(1,2-dimethoxy-2-oxoethyl)-1-methyl-4-oxoquinoline-3-carboxylate

methyl 2-(1,2-dimethoxy-2-oxoethyl)-1-methyl-4-oxoquinoline-3-carboxylate

C16H17NO6 (319.1056)


   

(11s,12r)-11,12-dihydroxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

(11s,12r)-11,12-dihydroxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

C18H13N3O3 (319.0957)


   

(4s)-4-benzyl-3-hydroxy-4h-pyrazino[2,1-b]quinazoline-1,6-dione

(4s)-4-benzyl-3-hydroxy-4h-pyrazino[2,1-b]quinazoline-1,6-dione

C18H13N3O3 (319.0957)


   

methyl 4-methyl-6-(1,4,6-trihydroxy-3-oxoisoindol-5-yl)hex-4-enoate

methyl 4-methyl-6-(1,4,6-trihydroxy-3-oxoisoindol-5-yl)hex-4-enoate

C16H17NO6 (319.1056)


   

methyl 2-[(1s)-1,2-dimethoxy-2-oxoethyl]-1-methyl-4-oxoquinoline-3-carboxylate

methyl 2-[(1s)-1,2-dimethoxy-2-oxoethyl]-1-methyl-4-oxoquinoline-3-carboxylate

C16H17NO6 (319.1056)


   

(1r,5r,6r,7r,9s,11s,13s,14r)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

(1r,5r,6r,7r,9s,11s,13s,14r)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

C11H17N3O8 (319.1016)


   

(1r,5r,6s,7s,9s,11s,12s,13s,14s)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

(1r,5r,6s,7s,9s,11s,12s,13s,14s)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

C11H17N3O8 (319.1016)


   

n-[(2s)-1-(3,4-dihydroxyphenyl)-3-hydroxypropan-2-yl]-3,4-dihydroxybenzenecarboximidic acid

n-[(2s)-1-(3,4-dihydroxyphenyl)-3-hydroxypropan-2-yl]-3,4-dihydroxybenzenecarboximidic acid

C16H17NO6 (319.1056)


   

(1r,5r,6r,7r,9s,11s,12r,13s,14s)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

(1r,5r,6r,7r,9s,11s,12r,13s,14s)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

C11H17N3O8 (319.1016)


   

(1r,2r,3r,4s,5r,6r,7s,11r)-2,3,4,5-tetrahydroxy-4-(hydroxymethyl)-9-imino-12-oxa-8,10-diazatricyclo[5.3.2.0¹,⁶]dodecane-11-carboxylic acid

(1r,2r,3r,4s,5r,6r,7s,11r)-2,3,4,5-tetrahydroxy-4-(hydroxymethyl)-9-imino-12-oxa-8,10-diazatricyclo[5.3.2.0¹,⁶]dodecane-11-carboxylic acid

C11H17N3O8 (319.1016)


   

(11s,13s)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

(11s,13s)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

C11H17N3O8 (319.1016)


   

(1r,5s,6r,7r,9s,11s,12s,13s,14s)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

(1r,5s,6r,7r,9s,11s,12s,13s,14s)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

C11H17N3O8 (319.1016)


   

10-hydroxy-10-[5-(hydroxymethyl)-1-methyl-2,4-dioxopyrrolidin-3-ylidene]deca-2,4,6,8-tetraenoic acid

10-hydroxy-10-[5-(hydroxymethyl)-1-methyl-2,4-dioxopyrrolidin-3-ylidene]deca-2,4,6,8-tetraenoic acid

C16H17NO6 (319.1056)


   

(1r,5r,6r,7s,9r,11s,13s,14s)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

(1r,5r,6r,7s,9r,11s,13s,14s)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

C11H17N3O8 (319.1016)


   

methyl 2-[(1r)-1,2-dimethoxy-2-oxoethyl]-1-methyl-4-oxoquinoline-3-carboxylate

methyl 2-[(1r)-1,2-dimethoxy-2-oxoethyl]-1-methyl-4-oxoquinoline-3-carboxylate

C16H17NO6 (319.1056)


   

11,12-dihydroxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

11,12-dihydroxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

C18H13N3O3 (319.0957)


   

(2e,4e,6e,8e)-10-hydroxy-10-[(3e,5s)-5-(hydroxymethyl)-1-methyl-2,4-dioxopyrrolidin-3-ylidene]deca-2,4,6,8-tetraenoic acid

(2e,4e,6e,8e)-10-hydroxy-10-[(3e,5s)-5-(hydroxymethyl)-1-methyl-2,4-dioxopyrrolidin-3-ylidene]deca-2,4,6,8-tetraenoic acid

C16H17NO6 (319.1056)